TP-16

CAS No. 2332972-26-4

TP-16( —— )

Catalog No. M35651 CAS No. 2332972-26-4

TP-16 is a novel potent and selective EP4 antagonist that blocks the function of IMCs and enhances cytotoxic T cell-mediated tumor elimination in vivo.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 377 In Stock
5MG 610 In Stock
10MG 820 In Stock
25MG 1207 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TP-16
  • Note
    Research use only, not for human use.
  • Brief Description
    TP-16 is a novel potent and selective EP4 antagonist that blocks the function of IMCs and enhances cytotoxic T cell-mediated tumor elimination in vivo.
  • Description
    TP-16 is a novel and selective EP4 antagonist with an IC50 of 2.1 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Prostaglandin Receptor
  • Recptor
    Prostaglandin Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2332972-26-4
  • Formula Weight
    439.5
  • Molecular Formula
    C24H22FNO4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(N[C@@H](C)C1=CC=C(C(O)=O)C=C1)(=O)C=2C3=C(SC2CC4=CC=C(F)C=C4)COCC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lu W, et al. Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer. EMBO Mol Med. 2021 Jan 11;13(1):e12798. ?
molnova catalog
related products
  • L-161982

    L-161982 is a selective antagonist of the EP4 receptor.

  • Camonagrel

    Camonagrel is a compound with inhibitory effects on Prostaglandin E2 (PGE2).

  • AM211

    AM211 is a potent and orally bioavailable antagonist of prostaglandin D2 (PGD2) receptor type 2 (DP2).